References
- Avigan J., Steinberg D., Gutman A., Mize C. E., Milne G. W. A. Alpha-decarboxylation, an important pathway for the degradation of phytanic acid in animals. Biochem. biophys. Res. Commun. 1966; 24: 838
- Bergström S., Borgström B., Tryding N., Westöö G. Intestinal Absorption and Metabolism of 2:2-Dimethylstearic Acid in the Rat. Biochem. J. 1954; 58: 604
- Clayton R. B., Bloch K. Biological Synthesis of Lanosterol and Agnosterol. J. Biol. Chem. 1956; 218: 305
- Den H. The biological oxidation of 2,2-dimethyl-octanoic acid. Biochim. biophys. Acta 1965; 98: 462
- Eldjarn L. Heredopathia atactica polyneuriti-formis (Refsum's disease)-a defect in the omega-oxidation mechanism of fatty acids. Scand. J. clin. Lab. Invest. 1965; 17: 178
- Eldjarn L., Try K., Stokke O. The ability of patients with heredopathia atactica polyneuriti-formis to ω-oxidize and degrade several isoprenoid branch-chained fatty structures. Scand. J. clin. Lab. Invest. 1966; 18: 141
- Kahlke W. Refsum-Syndrom. Lipoidchemische Untersuchungen bei 9 Fällen. Klin. Wschr. 1964; 42: 1011
- Karrer P., Epprecht A. Eine allgemeine Darstellungsmetode für 2-Methyl-3Alkyl-Naphto-chinone. Konstitution und Vitamin K-Wirkung. Helvet. chim. Acta 1940; 23: 273
- Klenk E., Kahlke W. Über das Vorkommen der 3, 7, 11, 15-Tetramethyl-hexadecansäure(Phy-tan-Säure) in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krank-heitsfall unbekannter Genese (Verdacht auf Heredopathia atactica polyneuritiformis (Refsum-Syndrom)). Hoppe-Seylers Z. Physiol. Chem. 1963; 333: 133
- Preiss B., Bloch K. ω-Oxidation of Long Chain Fatty Acids in Rat Liver. J. biol. Chem. 1964; 239: 85
- Robbins K. C. In vitro Enzymic Omega Oxidation of Medium-Chain Fatty Acids in Mammalian Tissue. Biochem. biophys. Acta 1968; 123: 531
- Shorland F. B., Hansen R. P., Prior I. A. M. The Effect of Phytanic Acid on the Fatty Acid Composition of the Lipids of the Rat with Further Observations on its Metabolism. Proc. 7th Int. Congr. Nutr., Hamburg, 1966. Verlag Friedr. Vieweg & Sohn GmbH, BraunschweigGermany, 399, Vol. 5
- Steinberg D., Herndon J. H., Uhlendorf B. W., Avigan J., Mize C. E., Fales H. M. The Enzymatic Defect in Refsum's Disease. J. Clin. Invest. 1967; 46: 1120
- Stokke O., Personal communication.
- Stokke O., Try K., Eldjarn L. α-Oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease. Biochim. biophys. Acta 1967; 144: 271
- Try K. Heredopathia atactica polyneuritiformis (Refsum's disease). The diagnostic value of phytanic acid determination in serum lipids. European Neurology
- Try K. Indications of only a Partial Defect in the α-Oxidation Mechanism in Refsum's Disease. Scand. J. clin. Lab. Invest. 1967; 20: 255
- Try K., Eldjarn L. Normalization of the Tricaprin Test for ω-Oxidation in Refsum's Disease upon Lowering of Serum Phytanic Acid. Scand. J. clin. Lab. Invest. 1967; 20: 294
- Try K., Stokke O., Eldjarn L. Two new cases of heredopathia atactica polyneuritiformis (Refsum's disease) demonstrated phytanic acid accumulation. Scand. J. clin. Lab. Invest. 1965; 17(Suppl. 86)195
- Tryding N. Intestinal absorption and metabolism of 2,2-dimethylstearic acid in man. Arkiv Kemi 1957; 11: 307
- Tryding N., Westöö G. On the metabolism of 2,2-dimethylnonadecanoic acid in man. Arkiv Kemi 1957; 11: 313
- Wakabayashi K., Shimazono N. Studies on ω-oxidation of fatty acids in vitro. Biochim. bio-phys. Acta 1963; 70: 132
- Williams R. T. Detoxification Mechanisms. Chapman & Hall Ltd, London 1959